Jonathan K. Armstrong, Georg Hempel, Susanne Koling, Linda S. Chan, Timothy Fisher, Herbert J. Meiselman and George Garratty Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients Cancer 110
Version of Record online: 21 MAY 2007 | DOI: 10.1002/cncr.22739
Rapid clearance of poly(ethylene glycol)-asparaginase (PEG-ASNase) has been reported for up to one-third of patients treated for acute lymphoblastic leukemia. The presence of antibody specific to poly(ethylene glycol) was very closely associated with undetectable serum ASNase activity in PEG-ASNase-treated patients.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field